Details for New Drug Application (NDA): 204445
✉ Email this page to a colleague
The generic ingredient in LITHIUM CARBONATE is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
Summary for 204445
Tradename: | LITHIUM CARBONATE |
Applicant: | Alembic |
Ingredient: | lithium carbonate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 204445
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LITHIUM CARBONATE | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 204445 | ANDA | Alembic Pharmaceuticals Limited | 46708-148 | 46708-148-08 | 80 TABLET, EXTENDED RELEASE in 1 CARTON (46708-148-08) |
LITHIUM CARBONATE | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 204445 | ANDA | Alembic Pharmaceuticals Limited | 46708-148 | 46708-148-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-148-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 300MG | ||||
Approval Date: | Jun 10, 2015 | TE: | RLD: | No |
Complete Access Available with Subscription